Literature DB >> 25990479

Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil.

Mila M B P Salcedo1,2, Andrea P S Damin3, Grasiela Agnes3, Suzana A Pessini4, Patricia El Beitune4, Claudio O P Alexandre3, Kathleen M Schmeler5, Gustavo Py Gomes da Silveira4.   

Abstract

PURPOSE: To investigate the prevalence of human papillomavirus (HPV) in cervical samples of pregnant and non-pregnant women in South-Brazil.
METHODS: A prospective study of 91 pregnant and 92 non-pregnant women with no previous history of cervical dysplasia or cancer was carried out. Cervical samples for HPV testing and cytology were collected in each trimester of pregnancy and in the puerperium for pregnant women and at matched intervals for the non-pregnant women. All samples were analyzed through PCR with consensus primers GP5+/GP6+. Genotyping was performed using specific primers. To control for confounding factors, the analysis of multivariate logistic regression was applied. The measure of odds ratio (OR) and the 95 % confidence interval (95 % CI) were used. The level of statistical significance was set at 5 % (P ≤ 0.05).
RESULTS: HPV DNA was detected in 23/91 (25.3 %) cervical samples from the pregnant women and in 12/92 (13 %) cervical samples from non-pregnant women (P = 0.035). There was a significant association among cervical HPV infection and young age, number of lifetime sexual partners, and the presence of abnormal cervical cytology. HPV16 and HPV18 were the viral types more frequently detected. Out of the 23 HPV-positive pregnant women, 17 (73.9 %) had normal cervical cytology.
CONCLUSION: Our results suggest a higher prevalence of HPV infection in pregnant vs. non-pregnant women. This finding may be related to the relative immunosuppression observed in pregnant women, outlining the importance of the appropriate monitoring of the viral infection in this specific population.

Entities:  

Keywords:  HPV DNA; Human papillomavirus; Pregnancy

Mesh:

Substances:

Year:  2015        PMID: 25990479     DOI: 10.1007/s00404-015-3752-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Screening for cervical cancer in imprisoned women in Brazil.

Authors:  Elaine Regina Prudêncio da Silva; Albert Schiaveto de Souza; Taiana Gabriela Barbosa de Souza; Daniel Henrique Tsuha; Ana Rita Barbieri
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

2.  Human Papillomavirus (HPV) Infection in Early Pregnancy: Prevalence and Implications.

Authors:  Deeksha Pandey; Vani Solleti; Gazal Jain; Anwesha Das; Kabekkodu Shama Prasada; Shobha Acharya; Kapaettu Satyamoorthy
Journal:  Infect Dis Obstet Gynecol       Date:  2019-03-24

3.  Detection of high-risk human papillomavirus (HPV) by the novel AmpFire isothermal HPV assay among pregnant women in Pemba Island, Tanzania.

Authors:  Naomi Christine Angela Juliana; Mohamed Hamad Juma; Roel Heijmans; Sander Ouburg; Said Mohammed Ali; Aishwarya Singh Chauhan; Amanhi Biobank Pemba; Sunil Sazawal; Servaas Antonie Morré; Saikat Deb; Elena Ambrosino
Journal:  Pan Afr Med J       Date:  2020-10-27

4.  Detection of urinary Chlamydia trachomatis, Mycoplasma genitalium and human papilloma virus in the first trimester of pregnancy by PCR method.

Authors:  Monireh Rahimkhani; A Mordadi; M Gilanpour
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-06-04       Impact factor: 3.944

5.  Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine.

Authors:  Jing Chen; Kusuma Gopala; P K Akarsh; Frank Struyf; Dominique Rosillon
Journal:  Open Forum Infect Dis       Date:  2019-12-04       Impact factor: 3.835

6.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.